Evaluation of Kinesophobia in Patients With Metabolic Syndrome
NCT ID: NCT04123132
Last Updated: 2020-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
96 participants
OBSERVATIONAL
2019-09-25
2020-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients aged 45-65 years diagnosed with metabolic syndrome and healthy controls will be included in the study. Patients with rheumatic and neurological diseases,history of trauma, gonarthrosis, lumbar disc hernia, previous fractures, fibromyalgia and those who have experienced pain for the last week will be excluded. The participants will be filled in the Short Form-36 (SF-36), the Hospital Anxiety and Depression Scale, and the Tampa Kinesiophobia Scale. 48 patients with MS and 48 healthy participants will be included in the study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Kinesiophobia and Physical Function in Elderly With Musculoskeletal Pain
NCT07272876
Kinesiophobia in Patients With Chronic Low Back Pain
NCT06190041
Comprehensive Kinesiophobia Rating Scale
NCT05566522
Kinesiophobia in Chronic Neck Pain
NCT06849999
Evaluation of the Presence and Effects of Kinesiophobia in Multiple Sclerosis
NCT06167447
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with metabolic syndrome
Kinesiophobia
The presence of kinesiofobia in patients with metabolic syndrome
Healthy controls
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Kinesiophobia
The presence of kinesiofobia in patients with metabolic syndrome
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Patients with neurologic disease
* Patients with history of trauma
* Patients with gonartrosis
* Pateints with fibromialgia
45 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Erol Olcok Corum Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dilek Eker Büyükşireci
Specialist doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dilek Eker Büyükşireci
Çorum, Central Anatolia, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08090081DEB
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.